Top

Orphanet Journal of Rare Diseases

Published in:

Open Access 01-12-2024 | Ehlers-Danlos Syndrome | Research

Patient interest in the development of a center for Ehlers-Danlos syndrome/hypermobility spectrum disorder in the Chicagoland region

Authors: Wendy Wagner, Tom A. Doyle, Clair A. Francomano, Dacre R. T. Knight, Colin M. E. Halverson

Published in: Orphanet Journal of Rare Diseases | Issue 1/2024

Abstract

Background

The Ehlers-Danlos Syndromes (EDS) are a group of connective tissue disorders that are hereditary in nature and characterized by joint hypermobility and tissue fragility. The complex nature of this unique patient population requires multidisciplinary care, but appropriate centers for such care do not exist in large portions of the country. Need for more integrated services has been identified in Chicagoland, or Chicago and its suburbs. In order to explore and begin to address barriers to seeking appropriate care facing EDS patients in this region, we developed an online survey which we circulated through EDS social media groups for Chicagoland patients.

Results

Three hundred and nine unique respondents participated. We found that there exists a strong medical need for and interest in the development of a center in the region, and participants reported that, if made available to them, they would make extensive and regular use of such a facility.

Conclusions

We conclude that the establishment of a collaborative medical center specializing in the diagnosis and treatment of EDS, Hypermobility Spectrum Disorder, and related disorders in the Chicagoland area would greatly benefit patients by providing comprehensive care, alleviate the burden on overworked healthcare providers, and contribute to the sustainability of medical facilities.

Available only for authorised users

Steinmann B, Royce PM, Superti-Furga A. The Ehlers-Danlos syndrome. In: Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects. 2nd ed. Wiley-Liss; 2003:1201.

Pyeritz RE. Ehlers-Danlos syndrome. N Engl J Med. 2000;342(10):730–2. https://doi.org/10.1056/NEJM200003093421009.CrossRefPubMed

Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet. 2017;175(1):8–26. https://doi.org/10.1002/ajmg.c.31552.CrossRefPubMed

Song B, Yeh P, Harrell J. Systemic manifestations of Ehlers-Danlos syndrome. Bayl Univ Med Center Proc. 2021;34(1):49–53. https://doi.org/10.1080/08998280.2020.1805714.CrossRef

Castori M, Morlino S, Celletti C, et al. Re-writing the natural history of pain and related symptoms in the joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet. 2013;161(12):2989–3004. https://doi.org/10.1002/ajmg.a.36315.CrossRef

De Wandele I, Rombaut L, Malfait F, De Backer T, De Paepe A, Calders P. Clinical heterogeneity in patients with the hypermobility type of Ehlers-Danlos Syndrome. Res Dev Disabil. 2013;34(3):873–81. https://doi.org/10.1016/j.ridd.2012.11.018.CrossRefPubMed

Committee on Selected Heritable Disorders of Connective Tissue and Disability, Board on Health Care Services, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Selected Heritable Disorders of Connective Tissue and Disability. (Volberding PA, Spicer CM, Cartaxo T, Wedge RA, eds.). National Academies Press; 2022:26431. doi:https://doi.org/10.17226/26431

Demmler JC, Atkinson MD, Reinhold EJ, Choy E, Lyons RA, Brophy ST. Diagnosed prevalence of Ehlers-Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case–control comparison. BMJ Open. 2019;9(11):e031365. https://doi.org/10.1136/bmjopen-2019-031365.CrossRefPubMedPubMedCentral

Gensemer C, Burks R, Kautz S, Judge DP, Lavallee M, Norris RA. Hypermobile Ehlers-Danlos syndromes: complex phenotypes, challenging diagnoses, and poorly understood causes. Dev Dyn. 2021;250(3):318–44. https://doi.org/10.1002/dvdy.220.CrossRefPubMed

10.

Halverson CME, Clayton EW, Garcia Sierra A, Francomano C. Patients with Ehlers-Danlos syndrome on the diagnostic odyssey: rethinking complexity and difficulty as a hero’s journey. Am J Med Genet. 2021;187(4):416–24. https://doi.org/10.1002/ajmg.c.31935.CrossRefPubMed

11.

Reuter PR, Fichthorn KR. Prevalence of generalized joint hypermobility, musculoskeletal injuries, and chronic musculoskeletal pain among American university students. PeerJ. 2019;7:e7625. https://doi.org/10.7717/peerj.7625.CrossRefPubMedPubMedCentral

12.

Clark CJ, Simmonds JV. An exploration of the prevalence of hypermobility and joint hypermobility syndrome in Omani women attending a hospital physiotherapy service: exploring the prevalence of joint hypermobility syndrome. Musculoskelet Care. 2011;9(1):1–10. https://doi.org/10.1002/msc.184.CrossRef

13.

Committee on Selected Heritable Disorders of Connective Tissue and Disability, Board on Health Care Services, Health and Medicine Division, National Academies of Sciences E and Medicine. Selected Heritable Disorders of Connective Tissue and Disability. (Volberding PA, Spicer CM, Cartaxo T, Wedge RA, eds.). National Academies Press; 2022. Accessed April 18, 2023. https://www.nap.edu/catalog/26431

14.

Cederlöf M, Larsson H, Lichtenstein P, Almqvist C, Serlachius E, Ludvigsson JF. Nationwide population-based cohort study of psychiatric disorders in individuals with Ehlers-Danlos syndrome or hypermobility syndrome and their siblings. BMC Psychiatry. 2016;16:207. https://doi.org/10.1186/s12888-016-0922-6.CrossRefPubMedPubMedCentral

15.

Are the Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Rare or Common? Ehlers-Danlos Society. Published 2023. Accessed on 26 April 2023. https://www.ehlers-danlos.com/is-eds-rare-or-common/

16.

Langhinrichsen-Rohling J, Lewis CL, McCabe S, et al. They’ve been BITTEN: reports of institutional and provider betrayal and links with Ehlers-Danlos Syndrome patients’ current symptoms, unmet needs and healthcare expectations. Ther Adv Rare Dis. 2021;2:263300402110220. https://doi.org/10.1177/26330040211022033.CrossRef

17.

Estrella E, Frazier PA. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States. Disabil Rehabilit. 2023. https://doi.org/10.1080/09638288.2023.2176554.CrossRef

18.

Bulbena A, Baeza-Velasco C, Bulbena-Cabré A, et al. Psychiatric and psychological aspects in the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):237–45. https://doi.org/10.1002/ajmg.c.31544.CrossRefPubMed

19.

Henderson FC, Austin C, Benzel E, et al. Neurological and spinal manifestations of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):195–211. https://doi.org/10.1002/ajmg.c.31549.CrossRefPubMed

20.

Fikree A, Chelimsky G, Collins H, Kovacic K, Aziz Q. Gastrointestinal involvement in the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):181–7. https://doi.org/10.1002/ajmg.c.31546.CrossRefPubMed

21.

Halverson CME, Penwell HL, Perkins SM, Francomano CA. Comorbidity, misdiagnoses, and the diagnostic odyssey in patients with hypermobile Ehlers-Danlos syndrome. Genet Med Open. 2023;1(1):1–8. https://doi.org/10.1016/j.gimo.2023.100812.CrossRef

22.

Anderson LK, Lane KR. The diagnostic journey in adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. J Am Assoc Nurse Pract. 2021;34(4):639–48. https://doi.org/10.1097/JXX.0000000000000672.CrossRefPubMed

23.

Schubart JR, Bascom R, Francomano CA, Bloom L, Hakim AJ. Initial description and evaluation of EDS ECHO: an international effort to improve care for people with the Ehlers-Danlos syndromes and hypermobility spectrum disorders. Am J Med Genet. 2021;187(4):609–15. https://doi.org/10.1002/ajmg.c.31960.CrossRefPubMed

24.

Eckstein L, Helm BM, Baud R, Francomano CA, Halverson C. Effects of hypermobile Ehlers‐Danlos syndrome patients on the workflow and professional satisfaction of genetic counselors. Published online 2023.

25.

Doyle TA, Conboy E, Halverson CME. Diagnostic deserts: community-level barriers to appropriate genetics services. Am J Med Genet Pt A. 2022. https://doi.org/10.1002/ajmg.a.63016.CrossRef

26.

Knight DRT, Confiado SM, Bruno KA, et al. Establishing an Ehlers-Danlos syndrome clinic: lessons learned. SN Compr Clin Med. 2022;4(1):138. https://doi.org/10.1007/s42399-022-01218-w.CrossRefPubMedPubMedCentral

27.

Knight DRT, Bruno KA, Gehin JM, et al. The impact of a group telemedicine program for chronic disease: a retrospective cohort survey study on hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder. Telemed e-Health. 2023;29(2):261–9. https://doi.org/10.1089/tmj.2022.0092.CrossRef

28.

The Ehlers-Danlos Society Centers and Networks of Excellence Program. The Ehlers-Danlos Society. Published 2023. Accessed on 26 April 2023. https://www.ehlers-danlos.com/the-ehlers-danlos-society-centers-of-excellence-program/

29.

Elangovan N. Method of preparing a document for survey instrument validation by experts. MethodsX. 2021;8.

30.

Doyle TA, Halverson CME. Use of complementary and alternative medicine by patients with hypermobile Ehlers-Danlos syndrome: a qualitative study. Front Med. 2022;9:1056438. https://doi.org/10.3389/fmed.2022.1056438.CrossRef

31.

Chopra P, Tinkle B, Hamonet C, et al. Pain management in the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):212–9. https://doi.org/10.1002/ajmg.c.31554.CrossRefPubMed

32.

Knoerl R, Lavoie Smith EM, Weisberg J. Chronic pain and cognitive behavioral therapy: an integrative review. West J Nurs Res. 2016;38(5):596–628. https://doi.org/10.1177/0193945915615869.CrossRefPubMed

33.

Halverson CME, Penwell HL, Francomano CA. Clinician-associated traumatization from difficult medical encounters: results from a qualitative interview study on the Ehlers-Danlos Syndromes. SSM Qual Res Health. 2023;3:100237. https://doi.org/10.1016/j.ssmqr.2023.100237.CrossRefPubMedPubMedCentral

34.

Ericson WB, Wolman R. Orthopaedic management of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):188–94. https://doi.org/10.1002/ajmg.c.31551.CrossRefPubMed

35.

Mittal N, Mina DS, McGillis L, et al. The GoodHope Ehlers Danlos Syndrome Clinic: development and implementation of the first interdisciplinary program for multi-system issues in connective tissue disorders at the Toronto General Hospital. Orphanet J Rare Dis. 2021;16(1):357. https://doi.org/10.1186/s13023-021-01962-7.CrossRefPubMedPubMedCentral

36.

Bennett SE, Walsh N, Moss T, Palmer S. Understanding the psychosocial impact of joint hypermobility syndrome and Ehlers-Danlos syndrome hypermobility type: a qualitative interview study. Disabil Rehabil. 2021;43(6):795–804. https://doi.org/10.1080/09638288.2019.1641848.CrossRefPubMed

Title: Patient interest in the development of a center for Ehlers-Danlos syndrome/hypermobility spectrum disorder in the Chicagoland region
Authors: Wendy Wagner
Tom A. Doyle
Clair A. Francomano
Dacre R. T. Knight
Colin M. E. Halverson
Publication date: 01-12-2024
Publisher: BioMed Central
Keyword: Ehlers-Danlos Syndrome
Published in: Orphanet Journal of Rare Diseases / Issue 1/2024
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/s13023-024-03109-w

2024 ASCO Annual Meeting

Springer Medicine

Patient interest in the development of a center for Ehlers-Danlos syndrome/hypermobility spectrum disorder in the Chicagoland region

Abstract

Background

Results

Conclusions

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

The efficacy of Carbamylglutamate impacts the nutritional management of patients with N-Acetylglutamate synthase deficiency

Genetic insights into the ‘sandwich fusion’ subtype of Klippel–Feil syndrome: novel FGFR2 mutations identified by 21 cases of whole-exome sequencing

A quantitative and qualitative analysis of patient group narratives suggests common biopsychosocial red flags of undiagnosed rare disease

Phenylketonuria from the perspectives of patients in Türkiye

Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study

Correction: The impact of osteogenesis imperfecta severity on oral health-related quality of life in Spain: a cross-sectional study